Reduction of bacteriuria and pyuria after ingestion of cranberry juice.

PubWeight™: 5.38‹?› | Rank: Top 1%

🔗 View Article (PMID 8093138)

Published in JAMA on March 09, 1994

Authors

J Avorn1, M Monane, J H Gurwitz, R J Glynn, I Choodnovskiy, L A Lipsitz

Author Affiliations

1: Program for the Analysis of Clinical Strategies, Brigham and Women's Hospital, Boston, MA 02115.

Associated clinical trials:

Identification of the Cranberry Juice Compounds That Prevent Urinary Tract Infections | NCT00087828

Articles citing this

Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev (1998) 13.09

Effect of Cranberry Capsules on Bacteriuria Plus Pyuria Among Older Women in Nursing Homes: A Randomized Clinical Trial. JAMA (2016) 3.85

Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ (2001) 3.37

Ways of measuring rates of recurrent events. BMJ (1996) 2.18

Urinary tract infections in adult general practice patients. Br J Gen Pract (2002) 2.10

Effectiveness of cranberry capsules to prevent urinary tract infections in vulnerable older persons: a double-blind randomized placebo-controlled trial in long-term care facilities. J Am Geriatr Soc (2014) 2.08

Women's views about management and cause of urinary tract infection: qualitative interview study. BMJ (2010) 2.03

Cranberry products inhibit adherence of p-fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells. J Urol (2007) 1.57

Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun (2009) 1.46

Dietary factors affecting susceptibility to urinary tract infection. Pediatr Nephrol (2004) 1.46

Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. BMC Infect Dis (2010) 1.39

Diagnosis and management of urinary tract infection in older adults. Infect Dis Clin North Am (2013) 1.30

In-vitro and in-vivo evidence of dose-dependent decrease of uropathogenic Escherichia coli virulence after consumption of commercial Vaccinium macrocarpon (cranberry) capsules. Clin Microbiol Infect (2008) 1.28

Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br J Pharmacol (2008) 1.27

Controversies in management: should general practitioners perform diagnostic tests on patients before prescribing antibiotics? BMJ (1999) 1.20

Urinary tract infections in older women: a clinical review. JAMA (2014) 1.19

Efficient sorption of polyphenols to soybean flour enables natural fortification of foods. Food Chem (2012) 1.07

Identification of a cranberry juice product that inhibits enteric CYP3A-mediated first-pass metabolism in humans. Drug Metab Dispos (2008) 1.03

Feasibility of cranberry capsule administration and clean-catch urine collection in long-term care residents. J Am Geriatr Soc (2010) 1.03

Pilot randomized controlled dosing study of cranberry capsules for reduction of bacteriuria plus pyuria in female nursing home residents. J Am Geriatr Soc (2012) 1.02

Recurrent urinary tract infection and urinary Escherichia coli in women ingesting cranberry juice daily: a randomized controlled trial. Mayo Clin Proc (2012) 1.00

Use of complementary and alternative medicine and self-rated health status: results from a national survey. J Gen Intern Med (2010) 0.96

Urinary tract infection in postmenopausal women. Korean J Urol (2011) 0.94

Cranberries and their bioactive constituents in human health. Adv Nutr (2013) 0.93

Iron-binding properties of plant phenolics and cranberry's bio-effects. Dalton Trans (2007) 0.93

Stable binding of alternative protein-enriched food matrices with concentrated cranberry bioflavonoids for functional food applications. J Agric Food Chem (2013) 0.90

Cranberry proanthocyanidins inhibit the adherence properties of Candida albicans and cytokine secretion by oral epithelial cells. BMC Complement Altern Med (2012) 0.89

Effects of long-term cranberry supplementation on endocrine pancreas in aging rats. J Gerontol A Biol Sci Med Sci (2011) 0.87

Coumaroyl iridoids and a depside from cranberry (Vaccinium macrocarpon). J Nat Prod (2007) 0.86

Reduction of bacteriuria and pyuria using cranberry juice. JAMA (1994) 0.85

The cranberry and the urinary tract. Eur J Clin Microbiol Infect Dis (2007) 0.84

Determination of anthocyanins in cranberry fruit and cranberry fruit products by high-performance liquid chromatography with ultraviolet detection: single-laboratory validation. J AOAC Int (2011) 0.84

Isolation of Specific Cranberry Flavonoids for Biological Activity Assessment. Food Chem (2009) 0.84

Antimicrobial traits of tea- and cranberry-derived polyphenols against Streptococcus mutans. Caries Res (2011) 0.83

Induction of a state of iron limitation in uropathogenic Escherichia coli CFT073 by cranberry-derived proanthocyanidins as revealed by microarray analysis. Appl Environ Microbiol (2010) 0.83

Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: a randomized study. Int Urogynecol J (2012) 0.82

Effects of cranberry extracts and ursolic acid derivatives on P-fimbriated Escherichia coli, COX-2 activity, pro-inflammatory cytokine release and the NF-kappabeta transcriptional response in vitro. Pharm Biol (2009) 0.82

Oral consumption of cranberry juice cocktail inhibits molecular-scale adhesion of clinical uropathogenic Escherichia coli. J Med Food (2011) 0.81

Cranberry juice-- a well-characterized folk-remedy against bacterial urinary tract infection. Wien Med Wochenschr (2007) 0.81

Cranberries and lower urinary tract infection prevention. Clinics (Sao Paulo) (2012) 0.80

An experimental implementation of chemical subtraction. J Pharm Biomed Anal (2007) 0.80

Nutritional therapy and infectious diseases: a two-edged sword. Nutr J (2006) 0.79

Cranberry (Vaccinium macrocarpon) oligosaccharides decrease biofilm formation by uropathogenic Escherichia coli. J Funct Foods (2015) 0.78

Urinary tract infection in older adults. Aging health (2013) 0.78

Possible Role of Plant Allelochemical in Clearance of Bacteria from the Gut of Spruce Budworm, Choristoneura fumiferana. Open Microbiol J (2010) 0.78

Effectiveness of intravesical hyaluronic acid with or without chondroitin sulfate for recurrent bacterial cystitis in adult women: a meta-analysis. Int Urogynecol J (2012) 0.78

Solidago, orthosiphon, birch and cranberry extracts can decrease microbial colonization and biofilm development in indwelling urinary catheter: a microbiologic and ultrastructural pilot study. World J Urol (2013) 0.78

Effects of cranberry juice on pharmacokinetics of beta-lactam antibiotics following oral administration. Antimicrob Agents Chemother (2009) 0.77

Cranberry juice for urinary tract infection in children. Can Fam Physician (2012) 0.77

Flavan-3-ol compounds from wine wastes with in vitro and in vivo antioxidant activity. Nutrients (2010) 0.77

Reduction of bacteriuria and pyuria using cranberry juice. JAMA (1994) 0.76

A prospective multi-center trial of Escherichia coli extract for the prophylactic treatment of patients with chronically recurrent cystitis. J Korean Med Sci (2010) 0.76

The Efficacy of Umbelliferone, Arbutin, and N-Acetylcysteine to Prevent Microbial Colonization and Biofilm Development on Urinary Catheter Surface: Results from a Preliminary Study. J Pathog (2016) 0.75

Antibiotic susceptibility of urinary isolates in nursing home residents consuming cranberry capsules versus placebo. Infect Control Hosp Epidemiol (2015) 0.75

Allergy to lingonberry: A case report. Clin Mol Allergy (2004) 0.75

Reduction of bacteriuria and pyuria using cranberry juice. JAMA (1994) 0.75

Reduction of bacteriuria and pyuria using cranberry juice. JAMA (1994) 0.75

Cranberry, feverfew, horse chestnut, and kava. West J Med (1999) 0.75

Cysticlean® a highly pac standardized content in the prevention of recurrent urinary tract infections: an observational, prospective cohort study. BMC Urol (2013) 0.75

Cranberries and Urinary Tract Infections: How Can the Same Evidence Lead to Conflicting Advice? Adv Nutr (2016) 0.75

Systematic Review of Interventions to Reduce Urinary Tract Infection in Nursing Home Residents. J Hosp Med (2017) 0.75

Articles by these authors

A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol (1994) 30.72

Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med (1994) 10.24

MDS Cognitive Performance Scale. J Gerontol (1994) 9.61

Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol (2001) 7.04

Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med (1991) 5.94

High-intensity strength training in nonagenarians. Effects on skeletal muscle. JAMA (1990) 5.45

A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med (1994) 5.04

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation (1998) 4.80

Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. Clin Pharmacol Ther (2008) 4.54

Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial. JAMA (1998) 4.36

Persistence of use of lipid-lowering medications: a cross-national study. JAMA (1998) 4.15

The effects of exercise on falls in elderly patients. A preplanned meta-analysis of the FICSIT Trials. Frailty and Injuries: Cooperative Studies of Intervention Techniques. JAMA (1995) 3.94

Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA (1994) 3.86

A prospective study of cigarette smoking and risk of cataract in men. JAMA (1992) 3.72

The relative risk of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. A case-control study. Microbial Keratitis Study Group. N Engl J Med (1989) 3.63

Examining product risk in context. Market withdrawal of zomepirac as a case study. JAMA (1993) 3.42

Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med (1987) 3.34

Light-to-moderate alcohol consumption and risk of stroke among U.S. male physicians. N Engl J Med (1999) 3.21

Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal. JAMA (1994) 3.15

Risk factors for adverse drug events among nursing home residents. Arch Intern Med (2001) 3.12

The incidence of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. N Engl J Med (1989) 3.11

Leg extensor power and functional performance in very old men and women. Clin Sci (Lond) (1992) 3.03

Delirium. The occurrence and persistence of symptoms among elderly hospitalized patients. Arch Intern Med (1992) 2.92

Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med (1996) 2.92

Optimising drug treatment for elderly people: the prescribing cascade. BMJ (1997) 2.89

Epidemiologic aspects of uveal melanoma. Surv Ophthalmol (1988) 2.85

Knowledge, patterns of care, and outcomes of care for generalists and specialists. J Gen Intern Med (1999) 2.76

Increased pulse pressure and risk of heart failure in the elderly. JAMA (1999) 2.74

Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med (1994) 2.62

Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst (1993) 2.52

Impact near the hip dominates fracture risk in elderly nursing home residents who fall. Calcif Tissue Int (1993) 2.50

HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA (1995) 2.46

Biomechanical gait alterations independent of speed in the healthy elderly: evidence for specific limiting impairments. Arch Phys Med Rehabil (1998) 2.38

Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health (1996) 2.33

A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA (1996) 2.27

Survival of spiral ganglion cells in profound sensorineural hearing loss: implications for cochlear implantation. Ann Otol Rhinol Laryngol (1989) 2.24

Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in Men. Hypertension (2000) 2.23

The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens (1997) 2.21

Relations of body fat distribution and height with cataract in men. Am J Clin Nutr (2000) 2.20

Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet (2000) 2.17

The risk factors and impact on survival of feeding tube placement in nursing home residents with severe cognitive impairment. Arch Intern Med (1997) 2.17

Calcium channel blockers and myocardial infarction. A hypothesis formulated but not yet tested. JAMA (1995) 2.15

Prescribing for seniors: neither too much nor too little. JAMA (1999) 2.14

Age-related alterations in the fractal scaling of cardiac interbeat interval dynamics. Am J Physiol (1996) 2.13

Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med (2001) 2.13

The renal effects of nonsteroidal anti-inflammatory drugs in older people: findings from the Established Populations for Epidemiologic Studies of the Elderly. J Am Geriatr Soc (1999) 2.12

Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitioners. J Am Geriatr Soc (1997) 2.09

Aging and the complexity of cardiovascular dynamics. Biophys J (1991) 2.02

A systematic overview of the incidence of posterior capsule opacification. Ophthalmology (1998) 1.98

Aging and the anticoagulant response to warfarin therapy. Ann Intern Med (1992) 1.97

The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Am J Epidemiol (1985) 1.95

Short-term functional outcomes of long-term care residents with pneumonia treated with and without hospital transfer. J Am Geriatr Soc (1997) 1.93

Postprandial hypotension: epidemiology, pathophysiology, and clinical management. Ann Intern Med (1995) 1.92

Acute delirium and functional decline in the hospitalized elderly patient. J Gerontol (1993) 1.91

Treatment for glaucoma: adherence by the elderly. Am J Public Health (1993) 1.90

Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women. Circulation (2001) 1.86

Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med (1997) 1.85

Definition of race and ethnicity in older people in Medicare and Medicaid. J Am Geriatr Soc (1999) 1.82

Evaluation of prior primary malignancy as a determinant of uveal melanoma. A case-control study. Ophthalmology (1989) 1.82

Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry (2001) 1.80

Survival of patients with metastases from uveal melanoma. Ophthalmology (1991) 1.80

Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics. Pharmacoepidemiol Drug Saf (2002) 1.79

Reduced hip extension during walking: healthy elderly and fallers versus young adults. Arch Phys Med Rehabil (2001) 1.79

Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly. J Gerontol (1992) 1.78

Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy. J Am Coll Cardiol (2001) 1.77

How do older persons define constipation? Implications for therapeutic management. J Gen Intern Med (1997) 1.75

Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology. Arch Intern Med (2000) 1.75

Gender- and age-related differences in heart rate dynamics: are women more complex than men? J Am Coll Cardiol (1994) 1.71

Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study. Ann Intern Med (1998) 1.71

Risk factors for delirium in hospitalized elderly. JAMA (1992) 1.70

Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD) Am Heart J (1999) 1.70

Open-loop and closed-loop postural control mechanisms in Parkinson's disease: increased mediolateral activity during quiet standing. Neurosci Lett (1995) 1.69

Zolpidem use and hip fractures in older people. J Am Geriatr Soc (2001) 1.68

Association of visual impairment with mobility and physical function. J Am Geriatr Soc (1994) 1.68

Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Ann Neurol (1996) 1.66

Noise and poise: Enhancement of postural complexity in the elderly with a stochastic-resonance-based therapy. Europhys Lett (2007) 1.64

Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease. J Gen Intern Med (1999) 1.64

The epidemiology and natural history of pressure ulcers in elderly nursing home residents. JAMA (1990) 1.64

Musculoskeletal disease research: should we analyze the joint or the person? J Rheumatol (1996) 1.63

Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Arch Ophthalmol (1990) 1.62

D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism. J Thromb Haemost (2006) 1.62

Correlates and management of nonmalignant pain in the nursing home. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology. J Am Geriatr Soc (1999) 1.60

Trends in medication choices for hypertension in the elderly. The decline of the thiazides. Hypertension (1995) 1.60

Assessing the comparative effectiveness of newly marketed medications: methodological challenges and implications for drug development. Clin Pharmacol Ther (2011) 1.59

Prospective study of moderate alcohol consumption and mortality in US male physicians. Arch Intern Med (1997) 1.58

Constipation in the elderly. J Am Geriatr Soc (1993) 1.56

A longitudinal analysis of nursing home outcomes. Health Serv Res (1998) 1.56

Duration of, and temporal trends (1994-1997) in, prehospital delay in patients with acute myocardial infarction: the second National Registry of Myocardial Infarction. Arch Intern Med (1999) 1.55

Syncope in an elderly, institutionalised population: prevalence, incidence, and associated risk. Q J Med (1985) 1.53

Analytic strategies for recurrent events in epidemiologic studies: background and application to hospitalization risk in the elderly. J Clin Epidemiol (2000) 1.53

The diffusion of a novel therapy into clinical practice: the case of sildenafil. Arch Intern Med (2000) 1.52

Age-related trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995). Am J Cardiol (1998) 1.51

Differences in discharge medication after acute myocardial infarction in patients with HMO and fee-for-service medical insurance. J Gen Intern Med (1999) 1.50